Market Overview:
The global botanical and herbal drug market is expected to grow at a CAGR of 6.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing prevalence of chronic diseases, rising consumer awareness about the benefits of botanical and herbal drugs, and growing demand for natural ingredients in pharmaceuticals. The prescription drug segment is expected to account for the largest share of the global botanical and herbal drug market in 2018. This segment is projected to grow at a CAGR of 7% during the forecast period. The growth in this segment can be attributed to factors such as rising incidence of chronic diseases, increasing consumer awareness about the benefits of prescription drugs over OTC drugs, and growing demand for novel therapeutics with fewer side effects. The cardiovascular application segment is expected to account for the largest share of the global botanical and herbal drug market in 2018.
Product Definition:
A botanical drug is a plant-derived drug. Herbalism is the study of medicinal plants. The use of botanical and herbal drugs dates back to prehistoric times.
Prescription Drug:
Prescription drug is a type of medication that is given to a patient by a doctor, physician or other healthcare professional after evaluating the patient's health condition and history. The primary difference between Over-the-Counter (OTC) and prescription drugs is that OTC products are sold without prescription while prescription drugs require medical diagnosis before sales. Prescription medicines are not sold to consumers directly but through pharmacies which act as intermediaries between manufacturer & consumer.
OTC:
OTC stands for Over-the-Counter and it's used to refer to products that can be purchased from a retail store without a prescription. OTC drugs are usually sold in small quantities, ranging from 4 grams to 2 kilograms. They do not require any special handling or storage requirements and can be sold directly to consumers by the manufacturer or through any other distribution channel.
Application Insights:
The other application segment that covers cancer, respiratory system and cardiovascular is anticipated to witness the fastest growth over the forecast period. The rising prevalence of chronic diseases such as cancer and respiratory disorders coupled with increasing healthcare expenditure is expected to drive demand for botanical drugs in these applications.
Cardiovascular was estimated as the largest application segment in 2017 owing to high usage of herbal drugs for treating heart related problems such as angina (chest pain), hypertension, stroke, etc. Moreover, increasing R&D activities by companies for developing novel products specific towards cardiology is further expected to contribute toward market growth during the forecast period.
On the other hand tumor segment held a share of 9% in 2017 owing to high usage of botanical drugs specifically designed against tumor cells which have shown promising results in clinical trials thus far.
Regional Analysis:
North America dominated the global market in terms of revenue share in 2017. The growth can be attributed to the presence of a large number of pharmaceutical companies involved in botanical drug development and approval. Moreover, increasing R&D investments by these companies coupled with growing consumer awareness regarding herbal medicines is expected to drive this regional market over the forecast period.
Asia Pacific is anticipated to witness lucrative growth during the forecast period owing to rising demand for natural products from countries such as China and India due to low cost benefits offered by synthetic drugs. Furthermore, economic development coupled with government support for improving healthcare infrastructure is likely boost product consumption over next eight years.
Growth Factors:
- Increasing demand for botanical and herbal drugs due to their therapeutic properties.
- Rising prevalence of chronic diseases such as cancer, diabetes, and heart diseases which are treated with botanical and herbal drugs.
- Growing awareness about the benefits of botanical and herbal drugs among consumers.
- Technological advancements in the field of extraction and purification of botanical compounds that is aiding in the development of new products.
Scope Of The Report
Report Attributes
Report Details
Report Title
Botanical and Herbal Drug Market Research Report
By Type
Prescription Drug, OTC
By Application
Cardiovascular, Tumor, Respiratory System, Other
By Companies
Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
139
Number of Tables & Figures
98
Customization Available
Yes, the report can be customized as per your need.
Global Botanical and Herbal Drug Market Report Segments:
The global Botanical and Herbal Drug market is segmented on the basis of:
Types
Prescription Drug, OTC
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Cardiovascular, Tumor, Respiratory System, Other
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Buchang Pharmaceuticals
- China TCM
- Tsumura
- Schwabe
- Tong Ren Tang
- Jumpcan Pharmaceutical
- Guangzhou Baiyunshan Pharmaceutical
- Yunnan Baiyao
- Tasly Holding Group
- Bionorica Se
- Huarun 999
- Taiji
- Weleda
- Kwangdong
- GW Pharmaceuticals
Highlights of The Botanical and Herbal Drug Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Prescription Drug
- OTC
- By Application:
- Cardiovascular
- Tumor
- Respiratory System
- Other
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Botanical and Herbal Drug Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Botanical and herbal drugs are medications that are derived from plants or herbs. These medications can be used to treat a variety of conditions, including pain, inflammation, and anxiety.
Some of the major companies in the botanical and herbal drug market are Buchang Pharmaceuticals, China TCM, Tsumura, Schwabe, Tong Ren Tang, Jumpcan Pharmaceutical, Guangzhou Baiyunshan Pharmaceutical, Yunnan Baiyao, Tasly Holding Group, Bionorica Se, Huarun 999, Taiji, Weleda, Kwangdong, GW Pharmaceuticals.
The botanical and herbal drug market is expected to register a CAGR of 6.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Botanical and Herbal Drug Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Botanical and Herbal Drug Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Botanical and Herbal Drug Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Botanical and Herbal Drug Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Botanical and Herbal Drug Market Size & Forecast, 2020-2028
4.5.1 Botanical and Herbal Drug Market Size and Y-o-Y Growth
4.5.2 Botanical and Herbal Drug Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Prescription Drug
5.2.2 OTC
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Cardiovascular
6.2.2 Tumor
6.2.3 Respiratory System
6.2.4 Other
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Botanical and Herbal Drug Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Botanical and Herbal Drug Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Prescription Drug
9.6.2 OTC
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Cardiovascular
9.10.2 Tumor
9.10.3 Respiratory System
9.10.4 Other
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Prescription Drug
10.6.2 OTC
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Cardiovascular
10.10.2 Tumor
10.10.3 Respiratory System
10.10.4 Other
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Prescription Drug
11.6.2 OTC
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Cardiovascular
11.10.2 Tumor
11.10.3 Respiratory System
11.10.4 Other
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Prescription Drug
12.6.2 OTC
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Cardiovascular
12.10.2 Tumor
12.10.3 Respiratory System
12.10.4 Other
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Prescription Drug
13.6.2 OTC
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Cardiovascular
13.10.2 Tumor
13.10.3 Respiratory System
13.10.4 Other
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Botanical and Herbal Drug Market: Competitive Dashboard
14.2 Global Botanical and Herbal Drug Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Buchang Pharmaceuticals
14.3.2 China TCM
14.3.3 Tsumura
14.3.4 Schwabe
14.3.5 Tong Ren Tang
14.3.6 Jumpcan Pharmaceutical
14.3.7 Guangzhou Baiyunshan Pharmaceutical
14.3.8 Yunnan Baiyao
14.3.9 Tasly Holding Group
14.3.10 Bionorica Se
14.3.11 Huarun 999
14.3.12 Taiji
14.3.13 Weleda
14.3.14 Kwangdong
14.3.15 GW Pharmaceuticals
